Pharma giant AstraZeneca announced on 16 November that it is planning to exit the manufacturing site in Bangalore ‘in due course.’ In its regulatory filing,...
On Thursday, AstraZeneca (NASDAQ:AZN) raised its full-year adjusted earnings forecast after Q3 profit and revenue topped analysts’ expectations due to sales of its key cancer...
On Friday, the Drugs Controller General of India (DCGI) has given its market approval to the drug Lynparza (Olaparib) as a monotherapy for the adjuvant...
Infopark Properties Ltd (IPL), a subsidiary of Tata Real Estate and Infrastructure Ltd, has raised Rs 1,900 crore through a two-year zero-coupon bond. As part...
Serum Institute of India Ltd, the world’s largest vaccine maker and a significant supplier of Covid-19 vaccines to developing countries, has raised its stockpile to...
AstraZeneca coronavirus vaccine registered 74 per cent efficacy at stopping vital diseases, according to the company’s US clinical trial results. The data was tested on...
Indian drugmaker Zydus Cadila has applied to the Central Drugs Standard Control Organisation (CDSCO) for emergency use approval of its Covid-19 vaccine, which showed a...
African Union Commission and the Africa Centres for Disease Control and Prevention (Africa CDC) have voiced concerns around the European Union ‘Green Pass’ which does...